Skip to main content
. 2023 Sep 25;24(19):14515. doi: 10.3390/ijms241914515

Table 3.

Differentially expressed circulating miRNAs after hydrocortisone administration.

miRNA 1 Time after the
Administration (h)
Small RNA-seq RT-qPCR
Level 2 log2 Fold-Change Level 2 log2 Fold-Change p-Value
chr3-33188 12 8.66 0.78 0.028
chrX-47614 48 4.19 1.10 0.028
chr20-23348 12 3.48 - −0.17 0.249
chrX-47606 36 3.34 - −0.04 0.753
miR-133a 3 2.98 1.25 0.028
miR-206 9 2.75 - −0.09 0.463
miR-1 3 2.63 1.29 0.046
chr3-32616 6 2.48 - −0.12 0.249
miR-122 48 2.32 2.88 0.028
chr7-41424 9 2.12 - 0.40 0.116
chr3-33188 3 −11.37 - 0.13 0.345
chr25-30007 12 −4.14 −2.69 0.028
miR-532-3p 9 −2.04 - 0.33 0.116
miR-451 6 −1.93 −1.42 0.028
miR-7 6 −1.80 −0.78 0.046
miR-144 6 −1.69 - −0.22 0.249
chr7-42879 12 −1.59 −2.90 0.028
miR-142-3p 36 −1.48 - −0.30 0.075
let-7a 48 −1.47 - −0.61 0.075
miR-200b 12 −1.46 - −0.43 0.173

1 List of the top 20 miRNAs most altered by hydrocortisone administration in small RNA-seq and their variations by RT-qPCR. The “chr” at the beginning of the name indicates novel miRNAs and the chromosome numbers where they are present. 2 Level indicates an increase (↑) or decrease (↓) in miRNA levels after hydrocortisone administration. The “-” indicates no significant difference.